Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 43.79
-0.52 (-1.17%)
At close: May 30, 2025, 2:57 PM CST
Bide Pharmatech Market Cap
Bide Pharmatech has a market cap or net worth of 3.84 billion as of June 2, 2025. Its market cap has increased by 35.88% in one year.
Market Cap
3.84B
Enterprise Value
3.53B
Revenue
1.14B
Ranking
n/a
PE Ratio
31.95
Stock Price
43.79
Market Cap Chart
Since October 11, 2022, Bide Pharmatech's market cap has decreased from 4.38B to 3.84B, a decrease of -12.26%. That is a compound annual growth rate of -4.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 3.84B | -11.58% |
| Dec 31, 2024 | 4.34B | -13.91% |
| Dec 29, 2023 | 5.04B | -5.42% |
| Dec 30, 2022 | 5.33B | 21.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 362.72B |
| Shenzhen Mindray Bio-Medical Electronics | 273.17B |
| WuXi AppTec | 181.57B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.11B |
| Sichuan Biokin Pharmaceutical | 120.77B |
| Aier Eye Hospital Group | 115.34B |
| Shanghai United Imaging Healthcare | 112.70B |
| Yunnan Baiyao Group Co.,Ltd | 100.78B |